Russia has introduced Enteromix, the world’s first mRNA-based cancer vaccine, which has shown 100% efficacy and no side effects in clinical trials. The breakthrough is being hailed as a major advancement in oncology, offering fresh hope for millions of cancer patients worldwide.
Currently in limited clinical use at select oncology centers in Russia, Enteromix is awaiting final approval from the Ministry of Health for nationwide rollout. Unlike chemotherapy and radiation, which often cause severe side effects, the vaccine was reported to be safe and well-tolerated during testing.
Built on the same mRNA technology used in COVID-19 vaccines, Enteromix trains the immune system to precisely target cancer cells while sparing healthy tissues. It is administered via a simple intramuscular injection, making it far less invasive than traditional treatments.
Experts say the vaccine could help patients battling lung, breast, pancreatic, and colorectal cancers, along with those resistant to chemotherapy or carrying genetic mutations. If approved, Enteromix could mark the beginning of a new era in cancer care, shifting from broad, aggressive treatments to personalized, targeted therapies.
This is a plan came true moment as Putin Claims Russia Nearing Cancer Vaccine Development
